本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Aurinia Pharmaceuticals Inc

7.59
+0.10001.34%
盘后7.57-0.0200-0.26%16:49 EDT
成交量:100.85万
成交额:759.40万
市值:10.25亿
市盈率:28.53
高:7.61
开:7.51
低:7.45
收:7.49
数据加载中...
2021/05/06

重要事件披露

8-K - Current report
2021/04/30

[修订]年度报告

10-K/A [Amend] - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/04/27

重要事件披露

8-K - Current report
2021/03/11

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/02/24

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2021/02/24

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/02/24

重要事件披露

8-K - Current report
2021/02/17

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/12

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/08

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/01/27

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/01/26

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/01/25

重要事件披露

8-K - Current report
2020/10/09

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/08/11

财报披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/08/11

财报披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/07/23

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/06/09

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2020/03/19

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]